Mark Russel, - Speech-Language Pathologist in Issaquah, WA

Mark Russel, is a Speech-language Pathologist based in Issaquah, Washington. Mark Russel is licensed to practice in Washington (license number LL00002826) and his current practice location is 319 Nw Dogwood St, Issaquah, Washington. He can be reached at his office (for appointments etc.) via phone at (425) 373-1315.

NPI number for Mark Russel is 1043565377 and his current mailing address is 319 Nw Dogwood St, Issaquah, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043565377.

Contact Information

Mark Russel,
319 Nw Dogwood St,
Issaquah, WA 98027-3216
(425) 373-1315
Not Available



Healthcare Provider's Profile

Full NameMark Russel
GenderMale
SpecialitySpeech-language Pathologist
Location319 Nw Dogwood St, Issaquah, Washington
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1043565377
  • Provider Enumeration Date: 07/24/2012
  • Last Update Date: 07/24/2012

Medical Identifiers

Medical identifiers for Mark Russel such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043565377NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist LL00002826 (Washington)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark Russel is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark Russel,
319 Nw Dogwood St,
Issaquah, WA 98027-3216

Ph: (425) 373-1315
Mark Russel,
319 Nw Dogwood St,
Issaquah, WA 98027-3216

Ph: (425) 373-1315

News Archive

Forest Laboratories' ceftaroline fosamil receives FDA Advisory Committee approval for CABP and cSSSI

Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration's (FDA) Anti-Infective Drugs Advisory Committee voted 21 - 0 in favor of approval of ceftaroline fosamil for the treatment of community acquired bacterial pneumonia (CABP) and voted 18 - 0 in favor of approval for complicated skin and skin structure infections (cSSSI).

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Salix Pharmaceuticals, Ltd. today reported that the Company held a pre-NDA meeting on December 8, 2009 with the FDA to discuss the Company's proposed new drug application (NDA) for rifaximin in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).

Long term oestrogen-only hormone replacement therapy increases breast cancer risk

According to new research women who take oestrogen-only hormone replacement therapy for 20 years or longer to treat the symptoms of menopause, put themselves at greater risk of developing breast cancer.

Beta-carotene from food sources is insufficient in substantial part of population

The intake of preformed vitamin A from animal products is not sufficient in parts of the population in the U.S., Europe and Asia. The vitamin A precursor beta-carotene therefore has an important function in providing for an adequate supply of total vitamin A, international carotenoid experts state in a recently published consensus answer.

Indian, WHO officials to meet to discuss managing cases of highly drug-resistant TB

Health officials from India and the WHO are scheduled to meet in Mumbai on Tuesday to discuss how to manage the cases of at least 12 patients infected with a highly drug-resistant tuberculosis (TB) strain, Bloomberg reports (Narayan, 1/17).

Read more News

› Verified 1 days ago


Speech-Language Pathologist in Issaquah, WA

Mrs. Nancy M Lestz, MA,CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 710 Nw Juniper St, Suite 110, Issaquah, WA 98027
Phone: 425-392-2631    Fax: 425-392-4631
Lynn Bonko, SLP-CCC
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 710 Nw Juniper St, Suite 110, Issaquah, WA 98027
Phone: 206-805-9108    
Jennifer Benoliel, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 710 Nw Juniper St, Issaquah, WA 98027
Phone: 425-392-4965    
Rebecca Kneepkens,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 5150 220th Ave Se, Issaquah, WA 98029
Phone: 425-837-6500    
Danielle Justine Hulse,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1495 Nw Gilman Blvd Ste 4, Issaquah, WA 98027
Phone: 425-392-2346    
Lauren Jones, CFY-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1871 Nw Gilman Blvd, Suite 2, Issaquah, WA 98027
Phone: 425-657-0620    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.